Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Genes, Chromosomes & Cancer|May 25, 1999
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumoursS J Ramus, L G Bobrow, P D Pharoah, et al.Journal of the National Cancer Institute|July 6, 2000
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53B A Werness, P Parvatiyar, S J Ramus, et al.Cancer Research|September 29, 1998
Identification of germ-line E-cadherin mutations in gastric cancer families of European originS A Gayther, K L Gorringe, S J Ramus, et al.British Journal of Cancer|February 24, 2011
Morphological predictors of BRCA1 germline mutations in young women with breast cancerM C Southey, S J Ramus, J G Dowty, et al.British Journal of Cancer|November 17, 2004
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutationsA S Whittemore, R R Balise, P D P Pharoah, et al.Pathology|December 27, 2011
Using tumour pathology to identify people at high genetic risk of breast and colorectal cancersJ L Hopper, M A Jenkins, J G Dowty, et al.British Journal of Cancer|September 10, 2009
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysisJ M Cunningham, R A Vierkant, T A Sellers, et al.British Journal of Cancer|February 26, 2009
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancerL Quaye, H Song, S J Ramus, et al.British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.British Journal of Cancer|January 8, 2009
Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association ConsortiumC L Pearce, A M Near, D J Van Den Berg, et al.Pageof 11